EE04489B1 - Atsüülpseudodipeptiidid, nende valmistamise meetod ja neid sisaldavad farmatseutilised kompositsioonid - Google Patents
Atsüülpseudodipeptiidid, nende valmistamise meetod ja neid sisaldavad farmatseutilised kompositsioonidInfo
- Publication number
- EE04489B1 EE04489B1 EEP200000791A EEP200000791A EE04489B1 EE 04489 B1 EE04489 B1 EE 04489B1 EE P200000791 A EEP200000791 A EE P200000791A EE P200000791 A EEP200000791 A EE P200000791A EE 04489 B1 EE04489 B1 EE 04489B1
- Authority
- EE
- Estonia
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- pseudodipeptides
- acyl
- Prior art date
Links
- 125000002252 acyl group Chemical group 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/10—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9801396 | 1998-06-30 | ||
| PCT/IB1999/001170 WO2000000462A1 (fr) | 1998-06-30 | 1999-06-23 | Nouveaux pseudodipeptides acyles, leur mode de preparation et les compositions pharmaceutiques en renfermant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EE200000791A EE200000791A (et) | 2002-02-15 |
| EE04489B1 true EE04489B1 (et) | 2005-06-15 |
Family
ID=9522667
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200000791A EE04489B1 (et) | 1998-06-30 | 1999-06-23 | Atsüülpseudodipeptiidid, nende valmistamise meetod ja neid sisaldavad farmatseutilised kompositsioonid |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US7157092B1 (de) |
| EP (1) | EP1091928B1 (de) |
| JP (1) | JP4699609B2 (de) |
| KR (1) | KR100766016B1 (de) |
| CN (1) | CN1168702C (de) |
| AR (1) | AR029877A1 (de) |
| AT (1) | ATE355266T1 (de) |
| AU (1) | AU761396B2 (de) |
| BR (1) | BR9911329A (de) |
| CA (1) | CA2337807C (de) |
| CZ (1) | CZ302062B6 (de) |
| DE (1) | DE69935330T2 (de) |
| DK (1) | DK1091928T3 (de) |
| EE (1) | EE04489B1 (de) |
| ES (1) | ES2284275T3 (de) |
| HU (1) | HUP0102475A3 (de) |
| PL (1) | PL195764B1 (de) |
| RU (1) | RU2223262C2 (de) |
| SK (1) | SK287073B6 (de) |
| TW (1) | TWI255808B (de) |
| WO (1) | WO2000000462A1 (de) |
Families Citing this family (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1168702C (zh) * | 1998-06-30 | 2004-09-29 | Om药业 | 酰基-二肽类化合物,其制备方法以及含有前述化合物的药物组合物 |
| WO2001046127A1 (fr) * | 1999-12-22 | 2001-06-28 | Om Pharma | Pseudodipeptides acyles porteurs d'un bras auxiliaire fonctionnalise |
| JP2004529100A (ja) * | 2001-01-30 | 2004-09-24 | ユニバーシティ オブ バージニア パテント ファウンデーション | スフィンゴシン−１−ホスフェートレセプターのアゴニストおよびアンタゴニスト |
| DE60234375D1 (de) | 2001-09-14 | 2009-12-24 | Cytos Biotechnology Ag | VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG |
| CA2487849A1 (en) | 2002-07-18 | 2004-01-29 | Cytos Biotechnology Ag | Hapten-carrier conjugates comprising virus like particles and uses thereof |
| AU2004224761A1 (en) | 2003-03-26 | 2004-10-07 | Cytos Biotechnology Ag | HIV-peptide-carrier-conjugates |
| EP2269638A3 (de) | 2004-05-28 | 2012-06-13 | GlaxoSmithKline Biologicals S.A. | Impfstoffzusammensetzungen mit Virosomen und einem Saponin-Adjuvans |
| GB0503337D0 (en) | 2005-02-17 | 2005-03-23 | Glaxosmithkline Biolog Sa | Compositions |
| AR054020A1 (es) | 2005-03-23 | 2007-05-30 | Glaxosmithkline Biolog Sa | Nuevo uso |
| CA2636139A1 (en) | 2005-12-14 | 2007-06-21 | Cytos Biotechnology Ag | Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity |
| GB0607088D0 (en) | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
| KR101515078B1 (ko) | 2005-12-22 | 2015-04-24 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 백신 |
| WO2007102081A2 (en) * | 2006-03-09 | 2007-09-13 | Om Pharma | Immunomodulatory compounds and treatment of diseases related to an overproduction of inflammatory cytokines |
| EP2476433A1 (de) | 2006-03-30 | 2012-07-18 | GlaxoSmithKline Biologicals S.A. | Immunogene Zusammensetzung |
| US8541559B2 (en) | 2006-06-12 | 2013-09-24 | Cytos Biotechnology Ag | Process for producing aggregated oligonucleotides |
| PT2422810E (pt) | 2006-07-17 | 2014-12-03 | Glaxosmithkline Biolog Sa | Vacina da gripe |
| US9364525B2 (en) | 2006-07-18 | 2016-06-14 | Glaxosmithkline Biologicals Sa | Vaccines for malaria |
| US8323664B2 (en) | 2006-07-25 | 2012-12-04 | The Secretary Of State For Defence | Live vaccine strains of Francisella |
| EP2433648A3 (de) | 2006-10-12 | 2012-04-04 | GlaxoSmithKline Biologicals S.A. | Impfstoff mit einem Öl-in-wasser-emulsionshilfsstoff |
| PL2137210T3 (pl) | 2007-03-02 | 2017-06-30 | Glaxosmithkline Biologicals Sa | Nowy sposób i kompozycje |
| PE20090146A1 (es) | 2007-04-20 | 2009-03-23 | Glaxosmithkline Biolog Sa | Composicion inmunogenica contra el virus influenza |
| CA2690708A1 (en) | 2007-06-26 | 2008-12-31 | Glaxosmithkline Biologicals S.A. | Vaccine |
| EP2020240A1 (de) * | 2007-07-30 | 2009-02-04 | Paul-Ehrlich-Institut Bundesamt für Sera und Impfstoffe | Verfahren und Substanzen zur Behandlung von Morbus Alzheimer |
| WO2009117035A1 (en) | 2007-12-19 | 2009-09-24 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Soluble forms of hendra and nipah virus f glycoprotein and uses thereof |
| JP5711972B2 (ja) | 2007-12-24 | 2015-05-07 | アイディー バイオメディカル コーポレイション オブ ケベック | 組換えｒｓｖ抗原 |
| ES2553113T3 (es) | 2008-04-16 | 2015-12-04 | Glaxosmithkline Biologicals S.A. | Vacuna |
| AU2009323996A1 (en) | 2008-12-03 | 2011-07-07 | Institut Pasteur | Use of phenol-soluble modulins for vaccine development |
| WO2010079081A1 (en) | 2009-01-07 | 2010-07-15 | Glaxosmithkline Biologicals S.A. | Methods for recovering a virus or a viral antigen produced by cell culture |
| GB0901411D0 (en) | 2009-01-29 | 2009-03-11 | Secr Defence | Treatment |
| GB0901423D0 (en) | 2009-01-29 | 2009-03-11 | Secr Defence | Treatment |
| US20110293660A1 (en) | 2009-02-06 | 2011-12-01 | Bruno Rene Andre | Novel method |
| PE20110992A1 (es) | 2009-02-17 | 2012-02-12 | Glaxosmithkline Biolog Sa | Composicion inmunogenica que comprende un antigeno del virus del dengue |
| GB0906234D0 (en) | 2009-04-14 | 2009-05-20 | Secr Defence | Vaccine |
| HUE028085T2 (en) | 2009-06-24 | 2016-11-28 | Glaxosmithkline Biologicals Sa | Recombinant RSV antigens |
| EP2445527A2 (de) | 2009-06-24 | 2012-05-02 | ID Biomedical Corporation of Quebec | Impfstoff |
| CA2768186A1 (en) | 2009-07-15 | 2011-01-20 | Novartis Ag | Rsv f protein compositions and methods for making same |
| GB0913680D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
| JP5774010B2 (ja) | 2009-09-25 | 2015-09-02 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | インフルエンザウイルスのための免疫拡散アッセイ |
| GB0919117D0 (en) | 2009-10-30 | 2009-12-16 | Glaxosmithkline Biolog Sa | Process |
| WO2011101332A1 (en) | 2010-02-16 | 2011-08-25 | Proyecto De Biomedicina Cima, S.L. | Compositions based on the fibronectin extracellular domain a for the treatment of melanoma |
| CA2797059A1 (en) | 2010-05-03 | 2011-11-10 | Glaxosmithkline Biologicals S.A. | Novel method |
| GB201009273D0 (en) | 2010-06-03 | 2010-07-21 | Glaxosmithkline Biolog Sa | Novel vaccine |
| EP2627352B1 (de) | 2010-10-15 | 2017-05-10 | GlaxoSmithKline Biologicals S.A. | Cytomegalovirus gb antigen |
| EP2505640A1 (de) | 2011-03-29 | 2012-10-03 | Neo Virnatech, S.L. | Impfstoffzusammensetzungen für vom Birnavirus übertragenen Krankheiten |
| CA2835644C (en) | 2011-05-13 | 2021-06-15 | Novartis Ag | Pre-fusion rsv f antigens |
| CN103533953A (zh) | 2011-05-17 | 2014-01-22 | 葛兰素史密丝克莱恩生物有限公司 | 针对肺炎链球菌的疫苗 |
| WO2013139744A1 (en) | 2012-03-18 | 2013-09-26 | Glaxosmithkline Biologicals S.A. | Method of vaccination against human papillomavirus |
| US20140037680A1 (en) | 2012-08-06 | 2014-02-06 | Glaxosmithkline Biologicals, S.A. | Novel method |
| AU2013301312A1 (en) | 2012-08-06 | 2015-03-19 | Glaxosmithkline Biologicals S.A. | Method for eliciting in infants an immune response against RSV and B. pertussis |
| BE1022174B1 (fr) | 2013-03-15 | 2016-02-24 | Glaxosmithkline Biologicals S.A. | Vaccin |
| ES3020582T3 (en) | 2013-07-26 | 2025-05-23 | Inst Nat Sante Rech Med | Methods and pharmaceutical compositions for the treatment of bacterial infections |
| MX2016001695A (es) | 2013-08-05 | 2016-05-02 | Glaxosmithkline Biolog Sa | Composiciones inmunogenas de combinacion. |
| JP6851827B2 (ja) | 2013-08-30 | 2021-03-31 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | 細胞培養中でのウイルスの大規模製造 |
| CN104436157A (zh) | 2013-09-23 | 2015-03-25 | 恩金生物有限公司 | 流感疫苗和治疗 |
| US10821175B2 (en) | 2014-02-25 | 2020-11-03 | Merck Sharp & Dohme Corp. | Lipid nanoparticle vaccine adjuvants and antigen delivery systems |
| WO2015165480A1 (en) | 2014-04-30 | 2015-11-05 | Institute For Research In Biomedicine | Human cytomegalovirus vaccine compositions and method of producing the same |
| MX384992B (es) | 2014-06-13 | 2025-03-14 | Glaxosmithkline Biologicals Sa | Combinaciones inmunógenas. |
| WO2016180852A1 (en) | 2015-05-12 | 2016-11-17 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods for preparing antigen-specific t cells from an umbilical cord blood sample |
| WO2016207408A1 (en) | 2015-06-26 | 2016-12-29 | Institute For Research In Biomedicine | Novel vaccines in prevention and treatment of malaria |
| GB201614799D0 (en) | 2016-09-01 | 2016-10-19 | Glaxosmithkline Biologicals Sa | Compositions |
| WO2018162450A1 (en) | 2017-03-06 | 2018-09-13 | Fundación Para La Investigación Médica Aplicada | New inmunostimulatory compositions comprising an entity of cold inducible rna-binding protein with an antigen for the activation of dendritic cells |
| WO2018193063A2 (en) | 2017-04-19 | 2018-10-25 | Institute For Research In Biomedicine | Novel malaria vaccines and antibodies binding to plasmodium sporozoites |
| EP3581201A1 (de) | 2018-06-15 | 2019-12-18 | GlaxoSmithKline Biologicals S.A. | Escherichia coli o157:h7 polypeptide und verwendungen davon |
| US11911553B2 (en) * | 2018-07-06 | 2024-02-27 | Fenwal, Inc. | Systems and methods for concentrating cells with a syringe and a centrifuge |
| WO2021014385A1 (en) | 2019-07-24 | 2021-01-28 | Glaxosmithkline Biologicals Sa | Modified human cytomegalovirus proteins |
| CN112329267B (zh) * | 2020-11-26 | 2022-08-16 | 中国核动力研究设计院 | 一种基于特征线法的组合几何中子输运处理方法及装置 |
| JP2023553854A (ja) | 2020-12-02 | 2023-12-26 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ドナー鎖補完性ｆｉｍｈ |
| WO2022162012A2 (en) | 2021-01-26 | 2022-08-04 | Eth Zurich | Antibodies broadly targeting coronaviruses and uses thereof |
| WO2022161598A1 (en) | 2021-01-26 | 2022-08-04 | Eth Zurich | Antibodies broadly targeting coronaviruses and uses thereof |
| WO2023144665A1 (en) | 2022-01-28 | 2023-08-03 | Glaxosmithkline Biologicals Sa | Modified human cytomegalovirus proteins |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61227586A (ja) * | 1985-03-30 | 1986-10-09 | Dai Ichi Seiyaku Co Ltd | ジサツカライド誘導体およびその塩 |
| JPS62129292A (ja) * | 1985-11-28 | 1987-06-11 | Toho Yakuhin Kogyo Kk | 生物活性を発現するリピドａ単糖類縁体 |
| US4746742A (en) * | 1985-11-28 | 1988-05-24 | Toho Yakuhin Kogyo Kabushiki Kaisha | Analogs of nonreducing monosaccharide moiety of lipid A |
| JPH0426662A (ja) * | 1990-05-23 | 1992-01-29 | Tosoh Corp | アミノ酸アシル誘導体及びその製造法 |
| DE4229877C2 (de) * | 1992-09-04 | 1994-09-15 | Max Delbrueck Centrum | Phospho- bzw. Phosphono-(N-acyl)-serine und ihre Herstellung |
| JPH06206893A (ja) * | 1992-09-07 | 1994-07-26 | Suntory Ltd | 新規なジサッカライド誘導体 |
| EP0668289A4 (de) * | 1993-09-07 | 1998-10-21 | Suntory Ltd | Disaccharid derivate. |
| PL181241B1 (pl) * | 1993-11-17 | 2001-06-29 | Deutsche Om Arzneimittel Gmbh | Disacharydy beta(1 6)glukozoaminowe, sposób wytwarzania disacharydu beta(1 6) glukozoaminowego, zawierająca je kompozycja farmaceutyczna i środek immunomodulujący i/lub przeciwnowotworowy oraz szczepionka |
| CN1168702C (zh) * | 1998-06-30 | 2004-09-29 | Om药业 | 酰基-二肽类化合物,其制备方法以及含有前述化合物的药物组合物 |
-
1999
- 1999-06-23 CN CNB998077615A patent/CN1168702C/zh not_active Expired - Fee Related
- 1999-06-23 JP JP2000557223A patent/JP4699609B2/ja not_active Expired - Fee Related
- 1999-06-23 DE DE69935330T patent/DE69935330T2/de not_active Expired - Lifetime
- 1999-06-23 US US09/720,045 patent/US7157092B1/en not_active Expired - Fee Related
- 1999-06-23 DK DK99957636T patent/DK1091928T3/da active
- 1999-06-23 ES ES99957636T patent/ES2284275T3/es not_active Expired - Lifetime
- 1999-06-23 KR KR1020007015066A patent/KR100766016B1/ko not_active Expired - Fee Related
- 1999-06-23 CA CA2337807A patent/CA2337807C/fr not_active Expired - Fee Related
- 1999-06-23 CZ CZ20004893A patent/CZ302062B6/cs not_active IP Right Cessation
- 1999-06-23 SK SK1887-2000A patent/SK287073B6/sk not_active IP Right Cessation
- 1999-06-23 WO PCT/IB1999/001170 patent/WO2000000462A1/fr not_active Ceased
- 1999-06-23 AU AU42848/99A patent/AU761396B2/en not_active Ceased
- 1999-06-23 EP EP99957636A patent/EP1091928B1/de not_active Expired - Lifetime
- 1999-06-23 RU RU2001102614/04A patent/RU2223262C2/ru not_active IP Right Cessation
- 1999-06-23 BR BR9911329-5A patent/BR9911329A/pt not_active Application Discontinuation
- 1999-06-23 PL PL99345040A patent/PL195764B1/pl not_active IP Right Cessation
- 1999-06-23 HU HU0102475A patent/HUP0102475A3/hu unknown
- 1999-06-23 EE EEP200000791A patent/EE04489B1/xx not_active IP Right Cessation
- 1999-06-23 AT AT99957636T patent/ATE355266T1/de not_active IP Right Cessation
- 1999-06-30 AR ARP990103172A patent/AR029877A1/es active IP Right Grant
- 1999-07-30 TW TW088112968A patent/TWI255808B/zh not_active IP Right Cessation
-
2006
- 2006-02-28 US US11/363,691 patent/US20060148678A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU761396B2 (en) | 2003-06-05 |
| PL345040A1 (en) | 2001-11-19 |
| SK18872000A3 (sk) | 2001-07-10 |
| CZ302062B6 (cs) | 2010-09-22 |
| US20060148678A1 (en) | 2006-07-06 |
| WO2000000462A1 (fr) | 2000-01-06 |
| DE69935330D1 (de) | 2007-04-12 |
| SK287073B6 (sk) | 2009-11-05 |
| PL195764B1 (pl) | 2007-10-31 |
| CN1306504A (zh) | 2001-08-01 |
| EE200000791A (et) | 2002-02-15 |
| CN1168702C (zh) | 2004-09-29 |
| KR100766016B1 (ko) | 2007-10-11 |
| BR9911329A (pt) | 2001-10-16 |
| HUP0102475A3 (en) | 2001-12-28 |
| US7157092B1 (en) | 2007-01-02 |
| KR20010083078A (ko) | 2001-08-31 |
| EP1091928A1 (de) | 2001-04-18 |
| EP1091928B1 (de) | 2007-02-28 |
| JP4699609B2 (ja) | 2011-06-15 |
| DK1091928T3 (da) | 2007-07-23 |
| HUP0102475A2 (hu) | 2001-11-28 |
| ATE355266T1 (de) | 2006-03-15 |
| AU4284899A (en) | 2000-01-17 |
| JP2002519338A (ja) | 2002-07-02 |
| CA2337807A1 (fr) | 2000-01-06 |
| AR029877A1 (es) | 2003-07-23 |
| ES2284275T3 (es) | 2007-11-01 |
| TWI255808B (en) | 2006-06-01 |
| CZ20004893A3 (en) | 2001-05-16 |
| DE69935330T2 (de) | 2007-10-31 |
| RU2223262C2 (ru) | 2004-02-10 |
| CA2337807C (fr) | 2012-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE04489B1 (et) | Atsüülpseudodipeptiidid, nende valmistamise meetod ja neid sisaldavad farmatseutilised kompositsioonid | |
| EE200000707A (et) | Oksasolidinooni derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid | |
| EE04498B1 (et) | Erütromütsiini derivaadid, nende valmistamismeetod ja neid sisaldav farmatseutiline kompositsioon | |
| EE200000168A (et) | Karboksamidotiasoolderivaadid, nende valmistamine ja neid sisaldavad farmatseutilised kompositsioonid | |
| EE04779B1 (et) | 1,3-dihüdro-2H-indool-2-ooni derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid | |
| EE04673B1 (et) | Kinoliini derivaadid, nende valmistamine ja kasutamine ravimina ning neid sisaldavad farmatseutilised kompositsioonid | |
| EE03929B1 (et) | Sünteetilised polüsahhariidid, nende valmistamisemeetod ja neid sisaldavad farmatseutilised kompositsioonid | |
| FI973148A7 (fi) | Substituoituja heterosyklisiä yhdisteitä, menetelmä niiden valmistamis eksi ja niitä sisältäviä farmaseuttisia koostumuksia | |
| EE9700333A (et) | Substitueeritud 4-fenüülaminotiasoolid, nende valmistamise meetod ja neid sisaldavad farmakoloogilised kompositsioonid | |
| EE04276B1 (et) | Kinoliini derivaadid, nende valmistamine ja kasutamine ravimina ning neid sisaldavad farmatseutilised kompositsioonid | |
| FI952550A7 (fi) | Uudet N-pyridyylikarboksamidit ja johdannaiset, menetelmät niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset | |
| EE9800426A (et) | Asendatud 2,4-tiasolidiindiooni derivaadid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid | |
| FI950625L (fi) | Polysubstituoituja 3-asyyliamino-5-fenyyli-1,4-bentsodiatsepiini-2-onijohdannaisia, menetelmä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia | |
| EE200000429A1 (et) | Sünteetilised polüsahhariidid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid | |
| EE03395B1 (et) | Bensotiasolooni derivaadid, protsessid ja kasutatud vaheühendid nende saamiseks ning neid sisaldavad ravimkoostised | |
| EE200000421A1 (et) | Uued pentasahhariidid, nende valmistamismeetodid ja neid sisaldavad farmatseutilised kompositsioonid | |
| EE03611B1 (et) | Taksoidid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid | |
| FI956278A0 (fi) | Substituoituja 4-fenyylitiatsolijohdannaisia, menetelmä niiden valmistamiseksi ja niitä sisältäviä farmaseuttisia koostumuksia | |
| FI950817A7 (fi) | Uudet bentsodioksaaniyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset | |
| FI960316L (fi) | Oksatiolaanit, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset | |
| FI955085L (fi) | Uudet diosmetiiniyhdisteet, menetelmä niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset | |
| EE04778B1 (et) | Hargnenud ahelaga asendatud 3-amino-1-fenüül-1H-[1,2,4]triasooli aminoderivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid | |
| EE03996B1 (et) | Farmatseutilised kompositsioonid, nende valmistamismeetod ja kasutamine | |
| FI951091A7 (fi) | Uudet alkyyliaminoindaaniyhdisteet, menetelmät niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset | |
| EE200100499A (et) | Uued morfoliini derivaadid, nende valmistamismeetod ja neid sisaldavad farmatseutilised kompositsioonid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB4A | Valid patent at the end of a year |
Effective date: 20051231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20061231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20071231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20081231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20101231 |
|
| MM4A | Lapsed by not paying the annual fees |
Effective date: 20130623 |